Complete Response of Acquired FV Inhibitor to Rituximab

Overview

Journal Int J Hematol

Specialty Hematology

Date 2015 Jan 25

PMID 25616916

Citations 1

Authors

Edmond S K Ma

Raymond H S Liang

Kent-Man Chu

George K K Lau

Affiliations

Soon will be listed here.

Citing Articles

A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors.

Kadohira Y, Yamada S, Hayashi T, Morishita E, Asakura H, Ichinose A Int J Hematol. 2018; 108(2):145-150.

PMID: 29611057 DOI: 10.1007/s12185-018-2453-z.

References

Lebrun A, Leroy-Matheron C, Arlet J, Bartolucci P, Michel M . Successful treatment with rituximab in a patient with an acquired factor V inhibitor. Am J Hematol. 2007; 83(2):163-4. DOI: 10.1002/ajh.21056. View

Ang A, Kuperan P, Ng C, Ng H . Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost. 2009; 101(5):852-9. View

Streiff M, Ness P . Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion. 2002; 42(1):18-26. DOI: 10.1046/j.1537-2995.2002.00011.x. View

Lian E, Tzakis A, Andrews D . Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis. Am J Hematol. 2004; 77(4):363-5. DOI: 10.1002/ajh.20181. View

Knobl P, Lechner K . Acquired factor V inhibitors. Baillieres Clin Haematol. 1999; 11(2):305-18. DOI: 10.1016/s0950-3536(98)80050-4. View